TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Vistin Pharma ASA
Closing information (x1000 SEK)
Closing information | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
Turnover | 241,334 | 205,421 | 186,037 |
Financial expenses | 5,042 | 87,671 | 6,772 |
Earnings before taxes | 88,907 | -87,393 | 7,367 |
Total assets | 533,345 | 512,302 | 231,970 |
Current assets | 417,472 | 398,822 | 158,187 |
Current liabilities | 77,477 | 137,621 | 96,949 |
Equity capital | 437,324 | 357,391 | 120,272 |
- share capital | 46,912 | 45,430 | 17,071 |
Employees (average) | 0 | 65 | |
Shareholders | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
Solvency | 82.0% | 69.8% | 51.8% |
Turnover per employee | 2,862 | ||
Profit as a percentage of turnover | 36.8% | -42.5% | 4.0% |
Return on assets (ROA) | 17.6% | 0.1% | 6.1% |
Current ratio | 538.8% | 289.8% | 163.2% |
Return on equity (ROE) | 20.3% | -24.5% | 6.1% |
Change turnover | 29,215 | 15,013 | -209,114 |
Change turnover % | 14% | 8% | -53% |
Chg. No. of employees | -65 | 65 | |
Chg. No. of employees % | -100% |
Total value of public sale
Fiscal year | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.